Previous close | 0.4423 |
Open | 0.4390 |
Bid | 0.0000 x 1800 |
Ask | 0.0000 x 1200 |
Day's range | 0.4010 - 0.4502 |
52-week range | 0.3100 - 4.3800 |
Volume | |
Avg. volume | 562,751 |
Market cap | 63.508M |
Beta (5Y monthly) | 0.98 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.8000 |
Earnings date | 07 Nov 2023 - 13 Nov 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.94 |
SAN DIEGO, September 21, 2023--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration shareholder rights plan (the "Rights Plan") to protect the long-term interests of all shareholders. The Board adopted the Rights Plan in response to a rapid accumulation of shares by a third party. The Rights Plan is effective immediately and has a one-year term, expiring on September 20, 2024.
SAN DIEGO, August 23, 2023--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences:
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 3.77% and 10.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?